"The patient, a 47-year-old mother of two, had for years been battling three severe autoimmune diseases, all of which were triggering her body to attack components of her blood."
"Müller and his colleagues have made a name for themselves pioneering experimental CAR-T cell treatments against a variety of autoimmune diseases, with promising early results."
"Small studies of CAR-T, as well as early results from several ongoing clinical trials, show that many people with autoimmune disease go into remission after treatment."
"After years of being intermittently lashed to machines and tubes, she hasn't needed a hospital stay in many months."
A 47-year-old woman suffering from three severe autoimmune diseases underwent experimental CAR-T cell treatment after multiple failed therapies. Confined to a hospital for over two months, she was treated with immunosuppressive drugs and blood transfusions. After receiving CAR-T therapy, she has returned to a mostly normal life without hospital stays for several months. Researchers are optimistic but cautious about the future of CAR-T technology in treating autoimmune diseases, noting its potential based on early results from clinical trials.
Read at The Atlantic
Unable to calculate read time
Collection
[
|
...
]